INFLUENCE OF DOSAGE FORM ON PAPAVERINE BIOAVAILABILITY

被引：8
|
作者：
MEYER, MC [1 ]
GOLLAMUDI, R [1 ]
STRAUGHN, AB [1 ]
机构：
[1] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,DEPT MED CHEM,MEMPHIS,TN 38163
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 8-9期
关键词：
D O I：
10.1002/j.1552-4604.1979.tb02505.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：435 / 444
页数：10
相关论文
共 50 条
  • [31] Development of an oral dosage form of azacitidine: Overcoming challenges in chemistry, formulation, and bioavailability.
    Stoltz, Maxine L.
    Etter, Jeffirey B.
    Obradovic, Tanja
    Jia, Richard
    BLOOD, 2006, 108 (11) : 298B - 298B
  • [32] Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers
    Wong, SL
    Linnen, P
    Mack, R
    Granneman, GR
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1997, 18 (06) : 533 - 541
  • [33] DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA .3. INFLUENCE OF DOSE ON PHARMACOKINETIC BEHAVIOR OF LEVODOPA IN DOGS AND PARKINSONIAN-PATIENTS
    SASAHARA, K
    NITANAI, T
    HABARA, T
    MORIOKA, T
    NAKAJIMA, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) : 1374 - 1378
  • [34] PAPAVERINE HYDROCHLORIDE - EVALUATION OF 2 NEW DOSAGE FORMS
    ARNOLD, JD
    BALDRIDGE, J
    RILEY, B
    BRODY, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1977, 15 (05): : 230 - 233
  • [35] DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA .2. BIOAVAILABILITY OF MARKETED LEVODOPA PREPARATIONS IN DOGS AND PARKINSONIAN-PATIENTS
    SASAHARA, K
    NITANAI, T
    HABARA, T
    MORIOKA, T
    NAKAJIMA, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (03) : 261 - 265
  • [36] BIOAVAILABILITY OF CEPHALEXINE DOSAGE FORMS
    JUNG, H
    PEREZ, R
    HERNANDEZ, L
    FUENTES, I
    RODRIGUEZ, JM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (16) : 2173 - 2183
  • [37] BIOAVAILABILITY AND DOSAGE OF DIHYDROERGOT ALKALOIDS
    WOODCOCK, BG
    RIETBROCK, N
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1983, 4 (02) : 54 - 55
  • [38] DOSAGE, COMPLIANCE AND BIOAVAILABILITY IN PERSPECTIVE
    BIRON, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1976, 115 (02) : 102 - 103
  • [39] DOSAGE, COMPLIANCE AND BIOAVAILABILITY IN PERSPECTIVE
    RUEDY, J
    DAVIES, RO
    GAGNON, MA
    MCLEAN, WM
    THOMPSON, WG
    VITTI, TG
    WILSON, TW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1977, 117 (04) : 323 - 324
  • [40] DOSAGE DEPENDENT BIOAVAILABILITY OF DIGOXIN
    OCHS, HR
    BODEM, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 1980, 69 (03): : 186 - 186
12345